Valiant Labs Board Meeting on Aug 10 to Approve Q1 FY27 Results

Valiant Laboratories Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda item for this meeting is the consideration and approval of the company's standalone and consolidated audited financial results for the first quarter ended June 30, 2026. Concurrently, the company has informed about the closure of its trading window, which began on June 26, 2026, and will extend until August 12, 2026, in compliance with SEBI regulations regarding insider trading. This announcement is in line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.